FDA approves drug for the "Pseudobulbar Effect" -

Avanir Drug Nuedexta Wins FDA Approval for Uncontrolled Laughing, Crying

By Rob Waters - Oct 29, 2010

Avanir Pharmaceuticals Inc. won U.S. approval for a drug that curbs bouts of uncontrolled laughing or crying in patients with neurological disorders, regulators said. Shares more than doubled in extended trading.

The medicine, Nuedexta, is the first approved to treat patients with multiple sclerosis or Lou Gehrig’s disease who develop symptoms known as pseudobulbar affect that causes loss of emotional control, the Food and Drug Administration said in a statement. Avanir, which has no other products on the market, plans to begin selling the drug in the first three months of 2011, the Aliso Viejo, California, company said in a statement.

READ MORE

***********************************************************

"Providing You with 'MS Views and News', is what we do"

Keep Informed and up-to-date with information concerning

 Multiple Sclerosis when registered at

the MS Views and News  website.

****************************************************************

Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

. ****************************************************************

Dr. Hubbard connects MS to CCSVI theory

Dr. Hubbard is a Neurologist (outside the field of MS) but has a son with Multiple Sclerosis and so therefore has a great interest in knowing more of this disease as well as how to reduce the effects

Dr. Hubbard says that for those with MS for many years, that CCSVI will not help them as it will not restore the already dead neurons. Yet though he claims to thwart disease progression for especially those newly diagnosed.

LISTEN to his story and what his new organization is doing for the CCSVI (Chronic Cerebro Venous Insuficciency) theory

CLICK HERE to watch and hear this video.

Make sure to listen to what he feels the surgery can help...

***********************************************************

"Providing You with 'MS Views and News', is what we do"

Keep Informed and up-to-date with information concerning

 Multiple Sclerosis when registered at

the MS Views and News  website.

****************************************************************

Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

. ****************************************************************

Over 200 are expected for the MS Symposium 2010 in Miami - a day filled with learning workshops for those affected by Multiple Sclerosis

  

          MS Symposium 
         2010

      An Educational Program for the MS Community        

     Saturday, November 13th, 2010

                                

Location: Intercontinental at Doral Miami

2505 NW 87th Avenue – Miami, Fl. 33172

Google Map - Just North of 836 on NW 87th Ave

}Doors open and registration begins at 9:00 am

  First Workshops starts at 10:00 am – Symposium ends at 3:00 pm

*FREE Admission                           *Complimentary Lunch

*Free Parking                                *An Educational Experience

*Information Display Tables                    

*Children permitted if 16 & older ONLY*                    

*From the Creator of the MS Health Expo, MS Views & News brings to you, the MS Symposium 2010.

*Information will be provided throughout the day by local Healthcare Providers, Alternative Therapists, Medical

  Equipment suppliers and others… 

*Come with a caregiver(s), and attend workshops designed for the MS patient by MS patients. Meet and socialize with MS friends while learning.

Educational Workshops / schedule:

¯  Personal Health & Wellness       10:00 am	¯  Physical Therapy and Balance       11:00 am	¯ Fatigue Management      12:00 pm
¯  Nutrition       10:00 am	¯  Psychological Implications on MS      11:00 am	¯ Urologic Implications on MS      12:00 pm
¯    LUNCH and our Open “Q&A” Session with local MS neurologists  begins at 1:15 pm ¯    Neurologists include: Drs. Steingo. Delgado, Calderon and Horstmyer
¯  MS and Sexuality 2:15 pm

** Reservations are required to attend this event.

}Meal tickets will be guaranteed only for people pre-registered.

To register, write to info@msviewsandnews.org  
 or call (954) 684-1683

  
Education Grants and Sponsorships for this program were provided by:

Biogen-Idec, Questcor, Teva, Medtronic, Bioness, POLOR Cooling Products, Genzyme, Genentech, The MS Foundation, UM Health Genetics Dept., Bayer Healthcare, Medics Ambulance Svce. and NSCFF, 

A comprehensive overview of the eight FDA-approved disease-modifying therapies used to slow MS activity (including the newly approved oral therapy, Gilenya), and initial findings on many of the experimental treatments in development for the treatment of MS

Information provided by: Cherie C. Binns RN BS MSCN

From the MS Association of America's Motivator Summer/Fall 2010 issue

Based on the positive response to the "MS Research Updates" published from 2007 through 2009 in New England Journal of Medicine, this year's article incorporates new information about the eight approved disease-modifying therapies (DMTs), as well as numerous experimental drugs currently under investigation for the treatment of MS. Highlights and recent study results are provided for each drug. This is not a complete list and not all information is included. Initial findings should be considered as preliminary, as additional studies and/or evaluations may be needed.

CLICK HERE to read this very well written / complete article on what we ( the MS patients), need to know to be kept informed and up-to-date.

***********************************************************

"Providing You with 'MS Views and News', is what we do"

Keep Informed and up-to-date with information concerning

 Multiple Sclerosis when registered at

the MS Views and News  website.

****************************************************************

Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

. ****************************************************************

Chat with others affected by Multiple Sclerosis....

Now offered to our MS Friends on Facebook, is our

 chat room called

 "Friends of Stu's Views and MS News" ...

Just recently created and there are already over

 100 people

 using this chat room.

Chat with others affected by MS, daily, weekly

 or hourly  by clicking here 

***********************************************************

"Providing You with 'MS Views and News', is what we do"

Keep Informed and up-to-date with information concerning

 Multiple Sclerosis when registered at

the MS Views and News  website.

****************************************************************

Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

. ****************************************************************

MS Patients Find Comfort, Flexibility In Yoga

Experts say with the right supervision, exercise can help manage symptoms of multiple sclerosis, and a special Staten Island yoga program could be helping improve outcomes among MS patients. NY1's Health reporter Kafi Drexel filed the following report.

Larissa Nusser and Denise Danton-Nizarre met eight years ago when Nusser attended Danton-Nizarre's first ever yoga class as a student living with multiple sclerosis.

"One of the issues she was having was balancing. Throughout the class, I kept saying to her, 'You can do it, you can do it, you can do it.' And that sort of became our theme," says Danton-Nizzare.

Nusser credits yoga with a dramatic change in her health outlook. So when they co-founded the You Can Do It Yoga Center in Richmond Valley, Staten Island, it seemed a natural fit to offer a special class for students living with MS. They have even created supplemental DVDs.

"I was diagnosed 10 years ago. I was in a wheelchair, actually, when I was diagnosed and I started transforming right in the first yoga class I went to," says Nusser.

Multiple sclerosis or MS, attacks the nervous system. According to the National Multiple Sclerosis Society, about 400,000 Americans are living with the disease and 200 people are newly diagnosed each week. Symptoms can be moderate, with numbness in the limbs. More severe symptoms can include paralysis or vision loss.

Read More and View a video found here

***********************************************************

"Providing You with 'MS Views and News', is what we do"

Keep Informed and up-to-date with information concerning

 Multiple Sclerosis when registered at

the MS Views and News  website.

****************************************************************

Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

. ****************************************************************

MSF Cruise For a Cause® CELEBRATES ITS 10TH YEAR OF CRUISING ABOARD THE OASIS OF THE SEAS

This is a promotion for the MS Foundation's Cruise for a Cause.


The largest and most revolutionary cruise ship in the world. An architectural marvel at sea, spanning 16 decks. Experience the most innovative and imaginative ship yet, Oasis of the Seas - where, for the first time ever, entertainment areas have become neighborhoods at sea.  Find a revolutionary public space combining nature with nautical in the Central Park neighborhood, or old-world charm with a modern twist in the entertaining Boardwalk neighborhood.  Visit the Pool and Sports Zone to explore an entire deck of pools and more.  And don't forget the Youth Zone - where kids can be kids and parents can be worry-free.  With seven distinct onboard neighborhoods, everyone can discover a place for unique experiences.

Now entering its tenth year, the MSF Cruise for a Cause provides an empowering adventure.  Traveling with fellow MS Cruisers, their families, as well as healthcare professionals, and of course, MSF staff, the trip is an unforgettable experience.

With the magnificent sun drenched and exotic Caribbean ports of St Thomas, St. Maarten and Bahamas as our ports of call, the Oasis of the Seas will make our 2011 Cruise for a Cause a dream come true for people with MS.

Some people with MS face unique challenges when traveling.  You may feel that you can no longer travel safely or comfortably. But these hurdles can be overcome, and the MSF Cruise for a Cause is a great place to start. On-board, courteous, and attentive staff caters to your needs.  Fine food, spectacular entertainment, great shopping, and exciting accessible portside activities are available as well.

Save these dates and join us!


September 10 to 17, 2011Cruise Line: Royal Caribbean
Ship: Oasis of the Seas
Destinations: Bahamas,St Thomas and St. Maarten
Departure: Fort Lauderdale FL 5:00 p.m. September 10, 2011.
Day 2: Nassau, Bahamas 7:00 a.m. -2:00 p.m.
Day 3: Cruising
Day 4: Charlotte Amalie, St. Thomas 9:00 a.m.-.5:00 p.m.
Day 5: Philipsburg St. Maarten 7:00 a.m.-5:00 p.m.
Day 6: Cruising
Day 7:  Cruising
Day 8: Arrive Fort Lauderdale.


READ More - including Pricing (per person) and other fees by clicking more

***********************************************************

"Providing You with 'MS Views and News', is what we do"

Keep Informed and up-to-date with information concerning

 Multiple Sclerosis when registered at

the MS Views and News  website.

****************************************************************

Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

. ****************************************************************

Early Treatment With Glatiramer Acetate Improved Outcomes in CIS (Clinically Isolated Syndrome)

October 25, 2010
By: SHARON WORCESTER, Internal Medicine News Digital Network

Patients with clinically isolated syndrome who receive early treatment with glatiramer acetate have more than a 40% reduction in the risk of developing multiple sclerosis, compared with those whose treatment is delayed, according to findings from a prospectively planned 5-year follow-up of patient in the phase III PreCISe study.

After a 2-year extension phase of the 3-year double-blind, placebo-controlled study, 33% of 80 patients who had received early treatment with glatiramer acetate (GA) developed clinically definite multiple sclerosis (CDMS), compared with 50% of 118 patients who began treatment at the end of the initial 3-year double-blind phase. Each patient received 20 mg of GA daily by subcutaneous injection.

Read More

***********************************************************

"Providing You with 'MS Views and News', is what we do"

Keep Informed and up-to-date with information concerning

 Multiple Sclerosis when registered at

the MS Views and News  website.

****************************************************************

Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

. ****************************************************************